Argenx
ARGX
#629
Rank
C$43.92 B
Marketcap
$724.64
Share price
0.98%
Change (1 day)
3.00%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : C$46.06 M

According to Argenx 's latest financial reports the company's total debt is C$46.06 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31C$16.86 M16.21%
2021-12-31C$14.5 M-3.61%
2020-12-31C$15.05 M41.3%
2019-12-31C$10.65 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31C$2.94 M1.75%
2011-12-31C$2.89 M